Tower Research Capital LLC (Trc) Aurinia Pharmaceuticals Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 715 shares of AUPH stock, worth $5,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
715
Previous 26,707
97.32%
Holding current value
$5,805
Previous $152,000
96.71%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AUPH
# of Institutions
209Shares Held
58.7MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$75.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$66.6 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$58.7 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.2 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.9 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.15B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...